ID   CT26
AC   CVCL_7254
SY   CT-26; CT 26; Colon Tumor 26
DR   BTO; BTO_0003630
DR   ABM; T8267
DR   BioGRID_ORCS_Cell_line; 1261
DR   ChEMBL-Cells; CHEMBL3308079
DR   ChEMBL-Targets; CHEMBL613866
DR   CLS; 305229
DR   KCB; KCB 2012007YJ
DR   KCLB; 80009
DR   Lonza; 1686
DR   NCBI_Iran; C532
DR   PubChem_Cell_line; CVCL_7254
DR   TOKU-E; 4093
DR   Wikidata; Q54814707
RX   PubMed=6992981;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-441.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/ct26-xenograft-model/
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from child cell line CT26.WT).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from child cell line CT26.WT).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
CH   CVCL_E8GY ! CT26-hCD39-LZ
CH   CVCL_E8GZ ! CT26-hEpCam-LZ
CH   CVCL_B7NN ! CT26-PD-L1 KO
CH   CVCL_C9FK ! CT26/Cas9-hyg
CH   CVCL_7256 ! CT26.WT
CH   CVCL_F1NN ! HyCyte CT26 KO-mAtm
CH   CVCL_E1JP ! HyCyte CT26 KO-mCd274
CH   CVCL_F1NP ! HyCyte CT26 KO-mParp1
CH   CVCL_F1NQ ! HyCyte CT26 KO-mPrkdc
CH   CVCL_D6B1 ! HyCyte CT26 KO-mSenp1
CH   CVCL_E1JQ ! HyCyte CT26 KO-mTmem176b
CH   CVCL_E3H3 ! HyCyte CT26-Luc
CH   CVCL_YJ79 ! LINTERNA CT-26
//
RX   PubMed=6992981;
RA   Brattain, Michael G.
RA   Strobel-Stevens, Janna Diane
RA   Fine, W. David
RA   Webb, Maryla
RA   Sarrif, Awni M.
RT   "Establishment of mouse colonic carcinoma cell lines with different
RT   metastatic properties.";
RL   Cancer Res. 40:2142-2146(1980).
//